Michael Robert A. (CIK 1699914) reported 10 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-03-03). Recent activity: Sell ABBV (36,523 shares), Buy ABBV (33,833 shares), Buy ABBV (12,030 shares), Buy ABBV (14,452 shares), Buy ABBV (22,124 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-03 | AbbVie Inc. (ABBV) | CHAIRMAN OF THE BOARD AND CEO | Sell | 36,523 | $8.5M |
| 2026-02-20 | AbbVie Inc. (ABBV) | CHIEF EXECUTIVE OFFICER | Buy | 33,833 | $0 |
| 2026-02-20 | AbbVie Inc. (ABBV) | CHIEF EXECUTIVE OFFICER | Buy | 12,030 | $0 |
| 2026-02-20 | AbbVie Inc. (ABBV) | CHIEF EXECUTIVE OFFICER | Buy | 14,452 | $0 |
| 2026-02-20 | AbbVie Inc. (ABBV) | CHIEF EXECUTIVE OFFICER | Buy | 22,124 | $0 |
| 2025-03-04 | AbbVie Inc. (ABBV) | CHIEF EXECUTIVE OFFICER | Sell | 27,186 | $5.6M |
| 2025-02-18 | AbbVie Inc. (ABBV) | CHIEF EXECUTIVE OFFICER | Buy | 24,732 | $0 |
| 2025-02-18 | AbbVie Inc. (ABBV) | CHIEF EXECUTIVE OFFICER | Buy | 10,146 | $0 |
| 2025-02-18 | AbbVie Inc. (ABBV) | CHIEF EXECUTIVE OFFICER | Buy | 12,030 | $0 |
| 2025-02-18 | AbbVie Inc. (ABBV) | CHIEF EXECUTIVE OFFICER | Buy | 14,454 | $0 |
Source: SEC Form 4 filings · as of 2026-03-03